Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Stefanny Christina
- Macquarie University Clinical Associates (MUCA) - Clinical Lead
- Faculty of Medicine, Health and Human Sciences
Person: Professional, Doctor of Philosophy
-
Blake Dear
- School of Psychological Sciences - Professor
- Macquarie University Clinical Associates (MUCA) - Clinical Advisor
Person: Professional, Teaching and research
-
Alexandra Dollman
- Macquarie Medical School - Conjoint Senior Lecturer
- Macquarie University Clinical Associates (MUCA) - Specialist Clinician - Respiratory (Motor Neurone Disease)
Person: Professional, Honorary academic
-
TROFUSE-032: CTU: A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer
Sabanathan, D. (Primary Chief Investigator), Chapman, N. (Clinical Trial Unit Staff), Quinlan, G. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), Garcia, M. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff), Delahunt Smoleniec, J. (Clinical Trial Unit Staff), TAIDI, G. (Clinical Trial Unit Staff) & Lawrie, A. (Clinical Trial Unit Staff)
11/11/25 → 11/11/30
Project: Research
-
OPERA-02: CTU: A Phase 3 Randomized, Double-Blind, Active-Controlled Study of Palazestrant with Ribociclib Versus Letrozole with Ribociclib for the First-Line Treatment of ER+, HER2– Advanced Breast Cancer (OPERA- 02)
Sabanathan, D. (Primary Chief Investigator), Quinlan, G. (Clinical Trial Unit Staff), Chapman, N. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), Garcia, M. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff), Lawrie, A. (Clinical Trial Unit Staff) & Delahunt Smoleniec, J. (Clinical Trial Unit Staff)
4/11/25 → 25/09/30
Project: Research
-
CTU: HRS-3802-101 A single-arm, open-label, multi-center phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics of HRS-3802 monotherapy in patients with malignant solid tumours
Sabanathan, D. (Primary Chief Investigator), Chapman, N. (Clinical Trial Unit Staff), Quinlan, G. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), Garcia, M. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff), Delahunt Smoleniec, J. (Primary Chief Investigator), Lawrie, A. (Clinical Trial Unit Staff) & TAIDI, G. (Clinical Trial Unit Staff)
4/11/25 → 11/08/26
Project: Research
-
Is dysphagia in multiple system atrophy responsive to levodopa? Results from a retrospective study
Gandor, F., Berger, L., Jäger, V., Demmin, K., Gruber, D., Schimming, K., Thimm, P., Ebersbach, G., Schreiber, S., Rowe, D. & Vogel, A., Mar 2026, In: Movement Disorders Clinical Practice. 13, 3, p. 683-691 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Link opens in a new tab Citations (Scopus) -
A new indocyanine green lymphography protocol for assessment of lymphedema in the head and neck
Suami, H., Gaitatzis, K., Mackie, H., Thompson, B., Blake, F. T., Forstner, D., Sundaresan, P., Skoracki, R. & Koelmeyer, L., Nov 2025, In: Otolaryngology - Head and Neck Surgery (United States). 173, 5, p. 1302-1306 5 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
A phase II trial of DB-1311/BNT324 (B7H3 ADC) combined with BNT327 (PD-L1 x VEGF-A bsAb) or DB-1305/BNT325 (TROP2 ADC) in advanced/metastatic solid tumors
Guo, Y., Gourdin, T. S., Chaudhry, A., Parsonson, A., Lin, C.-C., Jiang, L., Mu, H., Yang, Y., Fang, H., Qiu, Y., Shi, R., Tibes, R., Wenger, M., Furlanetto, J., Tureci, O., Sahin, U., Ren, Z. & Guo, J., Sept 2025, In: Annals of Oncology. 36, Supplement 2, p. S621 1 p., 1017eTiP.Research output: Contribution to journal › Meeting abstract › peer-review
Open Access
Prizes
-
2022 Winner - Excellence in Learning & Teaching - Teaching Excellence Prize
Koelmeyer, L. A. (Team leader), Thompson, B. (Recipient), Blackwell, R. (Recipient) & Tisdall Blake, F. (Recipient), Jul 2022
Prize
-
2022 Winner - Lighthouse Program Award – Innovation for ALERT Education Program
Koelmeyer, L. A. (Team leader), Thompson, B. (Recipient), Blackwell, R. (Recipient) & Tisdall Blake, F. (Recipient), Nov 2022
Prize: Teaching award
-
2023 Winner - Best Symposium Presentation - Teaching Excellence
Koelmeyer, L. A. (Team leader), Thompson, B. (Recipient), Blumfield, R. (Recipient), Blackwell, R. (Recipient) & Tisdall Blake, F. (Recipient), Feb 2023
Prize: Teaching award
-
The impact of a consensus process on implementation of interventions into healthcare settings: A qualitative study
Pagano, L. (Speaker), Long, J. (Speaker), Francis-Auton, E. (Speaker), Arnolda, G. (Speaker), Braithwaite, J. (Speaker), Hirschhorn, A. (Speaker) & Sarkies, M. (Speaker)
24 Sept 2024 → 27 Sept 2024Activity: Talk or presentation › Presentation
-
Developing the Local Consensus for Implementation Model
Pagano, L. (Speaker), Long, J. (Speaker), Francis-Auton, E. (Speaker), Braithwaite, J. (Speaker), Arnolda, G. (Speaker), Hirschhorn, A. (Speaker) & Sarkies, M. (Speaker)
5 Dec 2024Activity: Talk or presentation › Presentation
-
Implementation of consensus-based pathways to reduce variation in perioperative care in a private, academic health sciences centre
Pagano, L. (Speaker), Hirschhorn, A. (Speaker) & Sarkies, M. N. (Speaker)
20 Nov 2024Activity: Talk or presentation › Invited talk
Press/Media
Impacts
-
Improving health and spending money wisely: evaluating medicines and vaccines for the Australian Government
Cutler, H. (Participant), Parkinson, B. (Participant), Hoyle, M. (Participant), Mutowo, M. (Participant), Song, R. (Participant), Partington, A. (Participant), Jeet, V. (Participant), Seil, E. (Participant), Norman, A. (Participant), Mumford, V. (Participant), Vagholkar, S. (Participant), Pont, L. (Participant) & Amin, J. (Participant)
Impact: Quality of life impacts, Economy impacts, Policy impacts